NO954215D0 - Transdermal medikament-fremstilling - Google Patents

Transdermal medikament-fremstilling

Info

Publication number
NO954215D0
NO954215D0 NO954215A NO954215A NO954215D0 NO 954215 D0 NO954215 D0 NO 954215D0 NO 954215 A NO954215 A NO 954215A NO 954215 A NO954215 A NO 954215A NO 954215 D0 NO954215 D0 NO 954215D0
Authority
NO
Norway
Prior art keywords
pct
transdermal drug
drug preparation
sec
date
Prior art date
Application number
NO954215A
Other languages
English (en)
Other versions
NO311919B1 (no
NO954215L (no
Inventor
Wilfred Fischer
Thomas Struengmann
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of NO954215D0 publication Critical patent/NO954215D0/no
Publication of NO954215L publication Critical patent/NO954215L/no
Publication of NO311919B1 publication Critical patent/NO311919B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
NO19954215A 1993-04-23 1995-10-20 Transdermalt medikament NO311919B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4313402A DE4313402A1 (de) 1993-04-23 1993-04-23 Transdermale Wirkstoffzubereitung
PCT/EP1994/001259 WO1994025069A1 (de) 1993-04-23 1994-04-22 Transdermale wirkstoffzubereitung

Publications (3)

Publication Number Publication Date
NO954215D0 true NO954215D0 (no) 1995-10-20
NO954215L NO954215L (no) 1995-12-14
NO311919B1 NO311919B1 (no) 2002-02-18

Family

ID=6486248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19954215A NO311919B1 (no) 1993-04-23 1995-10-20 Transdermalt medikament

Country Status (13)

Country Link
US (1) US5738869A (no)
EP (1) EP0695193B1 (no)
JP (1) JP4334613B2 (no)
AT (1) ATE176593T1 (no)
AU (1) AU6721094A (no)
DE (2) DE4313402A1 (no)
DK (1) DK0695193T3 (no)
ES (1) ES2130420T3 (no)
FI (1) FI114444B (no)
GR (1) GR3029963T3 (no)
NO (1) NO311919B1 (no)
WO (1) WO1994025069A1 (no)
ZA (1) ZA942848B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US6623752B1 (en) * 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19641259A1 (de) * 1996-10-07 1998-04-16 Kade Pharma Fab Gmbh Arzneimittel auf Basis von Diclofenac
CN1072482C (zh) * 1996-11-08 2001-10-10 山东医科大学 低分子肝素脂质体喷胶剂及制备工艺
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19945522A1 (de) * 1999-09-23 2001-04-05 Hexal Ag Pharmazeutisches, wirkstoffhaltiges Gel
BR0001144B1 (pt) * 2000-02-21 2013-10-22 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10137082A1 (de) * 2001-07-28 2003-02-13 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
EP1572152B1 (en) * 2002-12-20 2008-02-13 Idexx Laboratories, Inc. Liposomal analgesic formulation comprising diclofenac and its use for treatment of horses
US6936273B2 (en) * 2002-12-20 2005-08-30 Idexx Laboratories, Inc. Liposomal analgesic formulation and use
EP1819297B1 (en) 2004-09-28 2015-01-14 Atrium Medical Corporation Uv cured gel and method of making
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
RU2392921C2 (ru) * 2005-03-31 2010-06-27 Унилевер Нв Улучшенная доставка агентов, полезных для кожи
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2666398C (en) 2006-10-17 2015-08-18 Ed Kisak Diclofenac gel
JP5371235B2 (ja) * 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
WO2009101412A1 (en) * 2008-02-13 2009-08-20 Cipla Limited Topical pharmaceutical composition
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US20110269704A1 (en) * 2009-07-24 2011-11-03 Seigfried Bernd G Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
DE102013004199A1 (de) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische Zusammensetzung
US20130309215A1 (en) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Fur Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmaceutical composition
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
JP6449554B2 (ja) * 2014-03-30 2019-01-09 小林製薬株式会社 外用医薬組成物
CA2972423A1 (en) 2014-12-31 2016-07-07 Lantheus Medical Imaging, Inc. Lipid-encapsulated gas microsphere compositions and related methods
JP6542006B2 (ja) * 2015-03-31 2019-07-10 小林製薬株式会社 外用医薬組成物
KR20240121345A (ko) 2016-05-04 2024-08-08 랜티우스 메디컬 이메징, 인크. 초음파 조영제의 제조 방법 및 장치
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
EP3528795A1 (de) * 2016-10-18 2019-08-28 LTS Lohmann Therapie-Systeme AG Zweischichtiges topisches therapeutisches system

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
DE3402928A1 (de) * 1984-01-28 1985-08-08 Roshdy Dipl.-Chem. Dr. 5000 Köln Ismail Mittel zur behandlung von herzerkrankungen
DE3588023D1 (de) * 1984-01-28 1995-06-29 Roshdy Ismail Mittel zur Behandlung von Herzerkrankungen.
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
ATE55905T1 (de) * 1984-03-07 1990-09-15 Roshdy Ismail Mittel zur behandlung und zum schutz der haut.
DE3507791A1 (de) * 1984-03-07 1985-09-26 Roshdy Ismail Mittel zum schutz der haut
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3506881A1 (de) * 1985-02-27 1986-08-28 RODISMA pharmazeutische Produkte GmbH, 5000 Köln Vitamin e spray
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US4745105A (en) * 1986-08-20 1988-05-17 Griffin Charles C Low molecular weight heparin derivatives with improved permeability
US4745107A (en) * 1986-08-20 1988-05-17 Foley Kevin M Heparin derivatives with improved permeability
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IT1229489B (it) * 1988-12-09 1991-09-03 Altergon Sa Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile
DE3904674A1 (de) * 1989-02-16 1990-08-23 Cassella Ag Verwendung einer wirkstoffkombination zur behandlung rheumatischer erkrankungen
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
EP0576605A4 (en) * 1991-03-19 1994-06-08 Vithal J Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions

Also Published As

Publication number Publication date
DK0695193T3 (da) 1999-09-20
FI954990A (fi) 1995-11-23
JPH08509715A (ja) 1996-10-15
GR3029963T3 (en) 1999-07-30
NO311919B1 (no) 2002-02-18
ES2130420T3 (es) 1999-07-01
ZA942848B (en) 1995-10-25
US5738869A (en) 1998-04-14
EP0695193B1 (de) 1999-02-10
DE59407810D1 (de) 1999-03-25
JP4334613B2 (ja) 2009-09-30
NO954215L (no) 1995-12-14
EP0695193A1 (de) 1996-02-07
DE4313402A1 (de) 1994-10-27
ATE176593T1 (de) 1999-02-15
FI114444B (fi) 2004-10-29
AU6721094A (en) 1994-11-21
WO1994025069A1 (de) 1994-11-10
FI954990A0 (fi) 1995-10-19

Similar Documents

Publication Publication Date Title
NO954215L (no) Transdermal medikament-fremstilling
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
NO952981D0 (no) Höyopplöselige flerkomponent-innleiringskomplekser inneholdende et basisk medikament, en syre og et cyklodekstrin
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
CY1105463T1 (el) Ελεγχομενη χορηγηση αντικαταθλιπτικων
ATE210435T1 (de) Retinal enthaltendes arzneimittel
DK0837706T3 (da) Influsionspumpe til medicinske væsker
AU2381402A (en) Small acid-soluble spore protein and uses thereof
FI963567A0 (fi) Diklofenakki-Na:a sisältävä depottabletti
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
ES2113549T3 (es) Metodo para inhibir la replicacion de vih empleando il-4.
NZ241234A (en) Amino polyhydroxy cyclohexane derivatives and medicaments
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
ZA963744B (en) Topical aciclovir preparation
AU5816396A (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees